BPMC
Balyasny Asset Management’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.9M | Buy |
505,957
+445,675
| +739% | +$57.1M | 0.1% | 195 |
|
|
2025
Q1 | $5.34M | Sell |
60,282
-42,204
| -41% | -$3.74M | 0.01% | 833 |
|
|
2024
Q4 | $8.94M | Buy |
102,486
+78,736
| +332% | +$6.87M | 0.01% | 703 |
|
|
2024
Q3 | $2.2M | Buy |
+23,750
| New | +$2.2M | ﹤0.01% | 1100 |
|
|
2024
Q1 | – | Sell |
-5,207
| Closed | -$480K | – | 2001 |
|
|
2023
Q4 | $480K | Buy |
+5,207
| New | +$480K | ﹤0.01% | 1438 |
|
|
2023
Q1 | – | Sell |
-941
| Closed | -$41.2K | – | 2226 |
|
|
2022
Q4 | $41.2K | Buy |
+941
| New | +$41.2K | ﹤0.01% | 1932 |
|
|
2022
Q1 | – | Sell |
-42,053
| Closed | -$4.5M | – | 2132 |
|
|
2021
Q4 | $4.5M | Buy |
42,053
+14,531
| +53% | +$1.56M | 0.02% | 741 |
|
|
2021
Q3 | $2.83M | Sell |
27,522
-87,637
| -76% | -$9.01M | 0.01% | 843 |
|
|
2021
Q2 | $10.1M | Buy |
+115,159
| New | +$10.1M | 0.05% | 461 |
|
|
2021
Q1 | – | Sell |
-125,827
| Closed | -$14.1M | – | 1582 |
|
|
2020
Q4 | $14.1M | Buy |
+125,827
| New | +$14.1M | 0.08% | 317 |
|
|
2020
Q2 | – | Sell |
-76,195
| Closed | -$4.46M | – | 972 |
|
|
2020
Q1 | $4.46M | Buy |
+76,195
| New | +$4.46M | 0.05% | 382 |
|
|
2018
Q4 | – | Sell |
-5,785
| Closed | -$452K | – | 1296 |
|
|
2018
Q3 | $452K | Buy |
+5,785
| New | +$452K | ﹤0.01% | 1188 |
|
|
2018
Q2 | – | Sell |
-227,549
| Closed | -$20.9M | – | 1598 |
|
|
2018
Q1 | $20.9M | Buy |
227,549
+184,049
| +423% | +$16.9M | 0.09% | 275 |
|
|
2017
Q4 | $3.28M | Sell |
43,500
-46,707
| -52% | -$3.52M | 0.01% | 805 |
|
|
2017
Q3 | $6.29M | Buy |
+90,207
| New | +$6.29M | 0.02% | 530 |
|